SCHEMBL30018877

SCHEMBL30018877

CP(C)(=S)c1c(Nc2nc(Cl)ncc2Cl)ccc2nccnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 5/20 0.40
▸ ADRA2A P08913 5/20 0.35
▸ ADRA2C P18825 5/20 0.35
▸ ADRA2B P18089 4/20 0.35
▸ ADRA1D P25100 4/20 0.35
▸ ADRA1A P35348 4/20 0.35
▸ ADRA1B P35368 4/20 0.35
▸ CCNA2 P20248 3/20 0.33
▸ CDK2 P24941 3/20 0.33
▸ CCNK O75909 2/20 0.33
▸ CCND3 P30281 2/20 0.33
▸ CDK9 P50750 2/20 0.33
▸ CDK6 Q00534 2/20 0.33
▸ ALK Q9UM73 3/20 0.33
▸ INSR P06213 2/20 0.32
▸ IGF1R P08069 2/20 0.32
▸ BCL6 P41182 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22595435 1.00 EGFR (0.40) EGFRADRA2AADRA2CADRA2BADRA1D
SCHEMBL30018868 0.88 EGFR (0.40) EGFRIGF1RMEN1KMT2A
SCHEMBL22588492 0.88 EGFR (0.40) EGFRIGF1RMEN1KMT2A
SCHEMBL29757745 0.88 EGFR (0.49) EGFRCDK9ALKINSRIGF1R
SCHEMBL22025609 0.88 EGFR (0.49) EGFRCDK9ALKINSRIGF1R
SCHEMBL27076009 0.79 BCL6 (0.38) EGFRADRA2AADRA2CADRA2BADRA1D
SCHEMBL22025610 0.78 CCNA2 (0.34) EGFRADRA2AADRA2CADRA2BADRA1D
SCHEMBL30741198 0.78 CCNA2 (0.34) EGFRADRA2AADRA2CADRA2BADRA1D
SCHEMBL31284251 0.78 EGFR (0.34) EGFRADRA2AADRA2CADRA2BADRA1D
SCHEMBL22026203 0.78 EGFR (0.45) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166103-B EGFR inhibitor and application thereof 江苏先声药业有限公司 2022-12-16 — — CN disclosed
Send feedback